A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

NCT03148418 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

Hoffmann-La Roche